Valentina Duga

Valentina Duga

Auto-generated profile, based on publicly available information

Valentina Duga

Child Neuropsychiatry Unit, Department of Pediatric Neuroscience Fondazione IRCCS Istituto Neurologico Carlo Besta Milano Italy

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 April 2024 in Movement Disorders
Verified
Journal Article
Open access
VDValentina Duga
Valentina Duga
RGRiccardo Giossi
Riccardo Giossi
Luigi Michele RomitoLuigi Michele Romito
Luigi Michele Romito
MSMario Stanziano
Mario Stanziano
VLVincenzo Levi
Vincenzo Levi
NNNardo Nardocci
Nardo Nardocci
Background: The evidence in the effectiveness of deep brain stimulation in children with medication‐refractory non‐degenerative monogenic dystonia is heterogeneous and long‐term results are sparse.Objectives: The objective is to describe long‐term outcomes in a single‐center cohort and compare our results with a meta‐analysis cohort form literature.Methods: We performed a retrospective single‐center cohort study including consecutive pediatric patients with non‐degenerative genetic or idiopathic dystonia treated with globus pallidus internus deep brain stimulation at our center and a systematic review and individual‐patient data meta‐analysis with the same inclusion criteria. The primary outcome was the change from baseline in the Burke‐Fahn‐Marsden Dystonia Rating Scale‐movement (BFMDRS‐M) score.Results: The clinical cohort included 25 patients with a mean study follow‐up of 11.4 years. The meta‐analysis cohort included 224 patients with a mean follow‐up of 3 years. Overall, the BFMDRS‐M mean improvements at 1 year and at last follow‐up were 41% and 33% in the clinical cohort and 58.9% and 57.2% in the meta‐analysis cohort, respectively. TOR1A‐dystonia showed the greatest and most stable BFMDRS‐M improvement in both cohorts at 1 year and at last follow‐up (76.3% and 74.3% in the clinical cohort; 69.6% and 67.3% in the meta‐analysis cohort), followed by SGCE‐dystonia (63% and 63.9% in the meta‐analysis cohort). THAP1‐dystonia (70.1% and 29.8% in the clinical cohort; 52.3% and 42.0% in the meta‐analysis cohort) and KMT2B‐dystonia (33.3% and 41.3% in the clinical cohort; 38.0% and 26.7% in the meta‐analysis cohort) showed a less pronounced or sustained response.Conclusion: Globus pallidus deep brain stimulation long‐term treatment seems effective with a possible gene‐specific differential effect. © 2024 The Authors. Movement Disorders published by Wiley Periodicals LLC on behalf of International Parkinson and Movement Disorder Society.

1 January 2021 in European Journal of Medical Genetics
Verified
Journal Article
Closed access
CCClaudia Ciaccio
Claudia Ciaccio
VDValentina Duga
Valentina Duga
CPChiara Pantaleoni
Chiara Pantaleoni
SESilvia Esposito
Silvia Esposito
IMIsabella Moroni
Isabella Moroni
CSClaudia Santoro
Claudia Santoro